Hoffman Reid's Form 4 filing
Vor Biopharma Inc. (VOR) · filed Sep 15, 2025
- Accession no.
- 0002050755-25-000007
- Filed
- Sep 15, 2025, 5:17 PM ET
- Trade date
- Sep 11-15, 2025
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market sales total $1.70M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Hoffman ReidCIK 0001519339 | 10% Owner |
| Reprogrammed Interchange LLCCIK 0002050755 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 11, 2025 | Common Stock | SSaleDisposed | −284,805 | $1.83 | −$521,420.99 | 33,928,487 | Direct | |
| Sep 12, 2025 | Common Stock | SSaleDisposed | −300,000 | $1.75 | −$526,230 | 33,628,487 | Direct | |
| Sep 15, 2025 | Common Stock | SSaleDisposed | −400,000 | $1.64 | −$656,320 | 33,228,487 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.